NRC vs SOLV
NRC: NRC Health offers an AI-powered healthcare experience management platform designed to help organizations improve patient and employee engagement through deep human insights. SOLV: A diversified healthcare technology and medical products provider focused on improving patient outcomes through specialized clinical tools and healthcare software solutions.
Side-by-side fundamentals
| Metric | NRC | SOLV | Edge |
|---|---|---|---|
| Price as of 2026-08-06 close | $19.47 | $82.96 | |
| Market cap as of 2026-08-08 | $431M | $14.1B | |
| P/E as of 2026-08-08 | 76.79 | 9.84 | SOLV lower |
| PEG as of 2026-08-08 | n/a | 0.04 | |
| Net margin as of 2026-08-08 | +4.2% | +17.3% | SOLV higher |
| Gross margin as of 2026-08-08 | +61.8% | +54.8% | NRC higher |
| Operating margin as of 2026-08-08 | +10.5% | +23.9% | SOLV higher |
| ROE as of 2026-08-08 | +48.5% | +29.0% | NRC higher |
| ROA as of 2026-08-08 | +4.3% | +10.1% | SOLV higher |
| Debt / equity as of 2026-08-08 | 13.75 | 1.10 | SOLV lower |
| Revenue growth (YoY) as of 2026-08-08 | -0.2% | -0.9% | NRC higher |
| Revenue CAGR (3y) SEC XBRL | -3.2% | +0.8% | SOLV higher |
| Dividend yield as of 2026-08-08 | +3.3% | n/a | |
| Dividend streak (yrs) SEC XBRL | 2 | n/a | |
| Beta as of 2026-08-08 | 0.27 | 0.58 | |
| 1-year return as of 2026-08-06 close | +37.5% | +14.3% | NRC higher |
Fundamentals: market data, as of 2026-08-08. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-06.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.